{
 "as_of": "2026-11-06",
 "cmr": "kr-cm-kg/KOSPI/326030",
 "fence": "The page is the record's research on the issuer — no analyst, no rating, no view.",
 "markdown": "The page is the record's research on the issuer — no analyst, no rating, no view.\n\n# SK biopharmaceuticals Co., Ltd. (KOSPI: 326030) — research page\n\nAs of 2026-11-06 · kr-cm-kg · record version 1\n\n## Identity and listing\n\nThe issuer is SK biopharmaceuticals Co., Ltd., listed on KOSPI under ticker 326030, ISIN KR7326030004, LEI 9845004573839986EA59. Its security type is Corporate, its sector is 자연과학 및 공학 연구개발업, and its jurisdiction is South Korea (DART filer with a corporate registration number). Its segment is not on the record. Its listing status is listed, not halted.\n\n## The disclosure read\n\nThe record holds 59 filings on 40 filing days in the twelve months to 2026-11-06. The median gap between filing days is 7 days. The latest filing is dated 2026-11-05 and is of type results, 1 day before the record date. Exchange peers on KOSPI carry 832 issuers, a median cadence gap of 7.0 days, a median of 49.0 filings and a median latency of 7.0 days. Sector peers carry 80 issuers, a median cadence gap of 7 days, a median of 42.5 filings and a median latency of 15 days.\n\n## Auditor\n\nThe auditor of record is 한영회계법인; its location is not on the record. Auditor changes are not on the record.\n\n## Events and halts\n\nListing, delisting, name change, domicile change and segment move are not on the record, because no lifecycle type map exists yet for this register. The halt flag reads listed, not halted.\n\n## Orderability\n\nThe outcome is not determinable for this issuer because the chapter's orderability section carries no client_categories, so the outcome cannot name its client category. The rule version is acm-68000/kr/suitability-and-appropriateness-fscma-articles-46-and-46-2/r1, with the chapter as of 2026-11-04.\n\n## Coverage\n\nThe field has not been read.\n\n## Open research\n\nThe field has not been read.\n\n## Licensed\n\nLicensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.\n\n## As-of depth\n\nThe vintage of this market is not sealed. The live record began on 2026-09-12. Years 2021, 2022, 2023, 2024, 2025 and 2026 are sealed in the store but are not served as of a date; the as-of door answers not_sealed.\n\n## Sources\n\n9 source pages are named on this page; every value above carries its own source page and read date in the numbers.\n\n- https://kind.krx.co.kr/corpgeneral/corpList.do?method=download&searchType=13 (identity.exchange)\n- https://data.krx.co.kr/comm/bldAttendant/getJsonData.cmd (identity.isin)\n- https://opendart.fss.or.kr/api/company.json?corp_code=00878696 (identity.jurisdiction)\n- https://api.gleif.org/api/v1/lei-records/9845004573839986EA59 (identity.lei)\n- https://mcp.kr-cm-kg.ai/events/KOSPI/326030 (the disclosure lines)\n- https://kind.krx.co.kr/investwarn/tradinghaltissue.do?method=searchTradingHaltIssueMain (the halt flag)\n- https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260318000773 (the auditor)\n- https://mcp.kr-cm-kg.ai/book/aio.json (the orderability chapter)\n- https://mcp.kr-cm-kg.ai/record/KOSPI/326030 (the record)\n",
 "market": "KR",
 "node": "kr-cm-kg",
 "numbers": {
  "as_of_depth": {
   "issuer_years_sealed": [],
   "live_record_began": "2026-09-12",
   "node_history_from": null,
   "node_years_sealed": [],
   "note": "6 years are sealed in the KR store; their Replay split is not built, so the as-of door answers not_sealed and the record is the live record as of 2026-11-06",
   "record_version": 1,
   "sealed": false,
   "store_years_sealed_not_served": [
    "2021",
    "2022",
    "2023",
    "2024",
    "2025",
    "2026"
   ]
  },
  "auditor": {
   "auditor": {
    "read_by": "DART API 회계감사인의 명칭 및 감사의견 (annual report 11011, business year 2025)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260318000773",
    "state": "sourced",
    "value": "한영회계법인"
   },
   "auditor_firm_id": {
    "market": "KR",
    "state": "not_on_record"
   },
   "auditor_location": {
    "market": "KR",
    "state": "not_on_record"
   },
   "changes": {
    "market": "KR",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   }
  },
  "cmr": "kr-cm-kg/KOSPI/326030",
  "coverage": {
   "note": "the coverage field has not been read for this issuer",
   "state": "not_read"
  },
  "disclosure": {
   "against": {
    "exchange": {
     "issuers": 832,
     "median_cadence_gap_days": 7,
     "median_filings": 49,
     "median_latency_days": 7,
     "name": "KOSPI"
    },
    "sector": {
     "issuers": 80,
     "median_cadence_gap_days": 7,
     "median_filings": 42.5,
     "median_latency_days": 15,
     "name": "자연과학 및 공학 연구개발업"
    }
   },
   "by_type": {
    "ad_hoc": 1,
    "agm_egm": 3,
    "corporate_news": 36,
    "directors_dealings": 4,
    "major_holder": 3,
    "regulatory_filing": 3,
    "results": 9
   },
   "cadence_median_gap_days": 7,
   "filing_days": 40,
   "filings": 59,
   "latency_days": 1,
   "latest": [
    {
     "category": null,
     "date": "2026-11-05",
     "source": "https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20261105800127",
     "title": "연결재무제표기준영업(잠정)실적(공정공시)",
     "type": "results"
    },
    {
     "category": null,
     "date": "2026-11-04",
     "source": "https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20261104800110",
     "title": "투자판단관련주요경영사항              (뇌전증 치료제 세노바메이트의 일차성 전신강직간대발작 적응증 미국 FDA 허가 신청)",
     "type": "corporate_news"
    },
    {
     "category": null,
     "date": "2026-11-02",
     "source": "https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20261102800256",
     "title": "기업설명회(IR)개최(안내공시)",
     "type": "corporate_news"
    },
    {
     "category": null,
     "date": "2026-09-10",
     "source": "https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260910800702",
     "title": "기업설명회(IR)개최(안내공시)",
     "type": "corporate_news"
    },
    {
     "category": null,
     "date": "2026-09-10",
     "source": "https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260910800675",
     "title": "투자판단관련주요경영사항              (뇌전증 신약 후보 물질 Opakalim의 미국 FDA 임상 2/3상 Partial Clinical Hold 통보 수령)",
     "type": "corporate_news"
    }
   ],
   "latest_filing_date": "2026-11-05",
   "read": "the node's event lines (list_events_since), as get_filings serves them",
   "source": "https://mcp.kr-cm-kg.ai/events/KOSPI/326030",
   "window": {
    "from": "2025-11-06",
    "to": "2026-11-06"
   }
  },
  "identity": {
   "exchange": {
    "read_by": "KIND (KRX) listed-company list (corpList.do download)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://kind.krx.co.kr/corpgeneral/corpList.do?method=download&searchType=13",
    "state": "sourced",
    "value": "KOSPI"
   },
   "isin": {
    "read_by": "KRX stock finder (data.krx.co.kr finder_stkisu: full_code = the KRX standard code)",
    "read_date": "2026-11-08",
    "read_date_basis": "the field",
    "source": "https://data.krx.co.kr/comm/bldAttendant/getJsonData.cmd  [POST bld=dbms/comm/finder/finder_stkisu, mktsel=ALL]",
    "state": "sourced",
    "value": "KR7326030004"
   },
   "jurisdiction": {
    "read_by": "DART company.json (company profile per corp_code, keyed API) (jurir_no)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://opendart.fss.or.kr/api/company.json?corp_code=00878696",
    "state": "sourced",
    "value": "South Korea (DART filer with a corporate registration number)"
   },
   "lei": {
    "read_by": "GLEIF registeredAs = DART corporate registration number (GLEIF golden copy 2026-09-12)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://api.gleif.org/api/v1/lei-records/9845004573839986EA59",
    "state": "filled",
    "value": "9845004573839986EA59"
   },
   "name": {
    "read_by": "DART company.json (company profile per corp_code, keyed API)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://opendart.fss.or.kr/api/company.json?corp_code=00878696",
    "state": "sourced",
    "value": "SK biopharmaceuticals Co., Ltd."
   },
   "sector": {
    "read_by": "KIND (KRX) listed-company list (corpList.do download) (업종)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://kind.krx.co.kr/corpgeneral/corpList.do?method=download&searchType=13",
    "state": "sourced",
    "value": "자연과학 및 공학 연구개발업"
   },
   "security_type": {
    "read_by": "KIND (KRX) listed-company list (corpList.do download)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://kind.krx.co.kr/corpgeneral/corpList.do?method=download&searchType=13",
    "state": "sourced",
    "value": "Corporate"
   },
   "segment": {
    "market": "KR",
    "state": "not_on_record"
   },
   "ticker": {
    "read_by": "KIND (KRX) listed-company list (corpList.do download)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://kind.krx.co.kr/corpgeneral/corpList.do?method=download&searchType=13",
    "state": "sourced",
    "value": "326030"
   },
   "website": {
    "read_by": "KIND (KRX) listed-company list (corpList.do download)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://kind.krx.co.kr/corpgeneral/corpList.do?method=download&searchType=13",
    "state": "sourced",
    "value": "www.skbp.com"
   }
  },
  "licensed": {
   "columns": [
    "licensor",
    "entitlement",
    "title",
    "date",
    "source"
   ],
   "rows": [],
   "rule": "A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded."
  },
  "lifecycle": {
   "delisting": {
    "market": "KR",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "domicile_change": {
    "market": "KR",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "listing": {
    "market": "KR",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "name_change": {
    "market": "KR",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "segment_move": {
    "market": "KR",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   }
  },
  "market": "KR",
  "node": "kr-cm-kg",
  "numbers_hash": "sha256:a333dbf07a3d60c2171bccb96f3e42e29c9bf94cf629db5d6d8f092aa9b27e08",
  "open_research": {
   "rows": [],
   "state": "not_read"
  },
  "orderability": {
   "chapter_as_of": "2026-11-04",
   "client_categories": [],
   "determinable": false,
   "read": {
    "chapter": "https://mcp.kr-cm-kg.ai/book/aio.json",
    "door": "https://mcp.kr-cm-kg.ai/mcp",
    "tool": "get_orderability"
   },
   "reason": "the chapter's orderability section carries no client_categories: the outcome cannot name its client category",
   "rule_version": "acm-68000/kr/suitability-and-appropriateness-fscma-articles-46-and-46-2/r1",
   "section": "kr.aio.v5"
  },
  "record": {
   "as_of": "2026-11-06",
   "url": "https://mcp.kr-cm-kg.ai/record/KOSPI/326030",
   "version": 1
  },
  "schema": "research-numbers v0.1 (USR-01, 2026-11-11)",
  "status": {
   "read_date": "2026-11-08",
   "source": "https://kind.krx.co.kr/investwarn/tradinghaltissue.do?method=searchTradingHaltIssueMain",
   "value": "listed, not halted"
  }
 },
 "numbers_hash": "sha256:a333dbf07a3d60c2171bccb96f3e42e29c9bf94cf629db5d6d8f092aa9b27e08",
 "path": "/kr/KOSPI/326030",
 "schema": "research-page v0.1 (USR-02, 2026-11-11)",
 "sections": [
  {
   "id": "identity",
   "text": "The issuer is SK biopharmaceuticals Co., Ltd., listed on KOSPI under ticker 326030, ISIN KR7326030004, LEI 9845004573839986EA59. Its security type is Corporate, its sector is 자연과학 및 공학 연구개발업, and its jurisdiction is South Korea (DART filer with a corporate registration number). Its segment is not on the record. Its listing status is listed, not halted.",
   "title": "Identity and listing"
  },
  {
   "id": "disclosure",
   "text": "The record holds 59 filings on 40 filing days in the twelve months to 2026-11-06. The median gap between filing days is 7 days. The latest filing is dated 2026-11-05 and is of type results, 1 day before the record date. Exchange peers on KOSPI carry 832 issuers, a median cadence gap of 7.0 days, a median of 49.0 filings and a median latency of 7.0 days. Sector peers carry 80 issuers, a median cadence gap of 7 days, a median of 42.5 filings and a median latency of 15 days.",
   "title": "The disclosure read"
  },
  {
   "id": "auditor",
   "text": "The auditor of record is 한영회계법인; its location is not on the record. Auditor changes are not on the record.",
   "title": "Auditor"
  },
  {
   "id": "events",
   "text": "Listing, delisting, name change, domicile change and segment move are not on the record, because no lifecycle type map exists yet for this register. The halt flag reads listed, not halted.",
   "title": "Events and halts"
  },
  {
   "id": "orderability",
   "text": "The outcome is not determinable for this issuer because the chapter's orderability section carries no client_categories, so the outcome cannot name its client category. The rule version is acm-68000/kr/suitability-and-appropriateness-fscma-articles-46-and-46-2/r1, with the chapter as of 2026-11-04.",
   "title": "Orderability"
  },
  {
   "id": "coverage",
   "text": "The field has not been read.",
   "title": "Coverage"
  },
  {
   "id": "open_research",
   "text": "The field has not been read.",
   "title": "Open research"
  },
  {
   "id": "licensed",
   "text": "Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.",
   "title": "Licensed"
  },
  {
   "id": "depth",
   "text": "The vintage of this market is not sealed. The live record began on 2026-09-12. Years 2021, 2022, 2023, 2024, 2025 and 2026 are sealed in the store but are not served as of a date; the as-of door answers not_sealed.",
   "title": "As-of depth"
  },
  {
   "id": "sources",
   "text": "9 source pages are named on this page; every value above carries its own source page and read date in the numbers.",
   "title": "Sources"
  }
 ],
 "sources": [
  {
   "for": "identity.exchange",
   "source": "https://kind.krx.co.kr/corpgeneral/corpList.do?method=download&searchType=13"
  },
  {
   "for": "identity.isin",
   "source": "https://data.krx.co.kr/comm/bldAttendant/getJsonData.cmd"
  },
  {
   "for": "identity.jurisdiction",
   "source": "https://opendart.fss.or.kr/api/company.json?corp_code=00878696"
  },
  {
   "for": "identity.lei",
   "source": "https://api.gleif.org/api/v1/lei-records/9845004573839986EA59"
  },
  {
   "for": "the disclosure lines",
   "source": "https://mcp.kr-cm-kg.ai/events/KOSPI/326030"
  },
  {
   "for": "the halt flag",
   "source": "https://kind.krx.co.kr/investwarn/tradinghaltissue.do?method=searchTradingHaltIssueMain"
  },
  {
   "for": "the auditor",
   "source": "https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260318000773"
  },
  {
   "for": "the orderability chapter",
   "source": "https://mcp.kr-cm-kg.ai/book/aio.json"
  },
  {
   "for": "the record",
   "source": "https://mcp.kr-cm-kg.ai/record/KOSPI/326030"
  }
 ],
 "title": "SK biopharmaceuticals Co., Ltd. (326030) — research page",
 "writer": {
  "by": "Claude through the platform account, Haiku class; one pass; checked against the numbers",
  "engine": "claude-haiku-5-5"
 }
}